arrow
A

Andréas Mackensen

friedrich-alexander-universität erlangen-nürnberg and uniklinikum erlangen
H指数:73
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells

系统性硬化症患者经CD19-CAR T细胞治疗后皮肤组织重塑的深度表型分析

2026-05-230
OAAI
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome

CD19 CAR-T疗法诱导难治性自身免疫性溶血性贫血伴ITP和抗磷脂综合征的缓解

Med
IF11.8
2026-04-090
PRE
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases

Anti-CD19 CAR T细胞治疗难治性自身免疫性疾病的儿科患者

2026-02-050
PRE
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

CD19 CAR-T细胞治疗难治性自身免疫性疾病:CASTLE篮式试验的1/2期研究

2026-01-070
OAAI
Functional differences between CLL- and ALL-derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL-10 as potential modulatory targets

CLL和ALL来源的CAR T细胞在3D肿瘤微环境中的功能差异突出了CXCR4和IL-10作为潜在的调节靶点。

2025-12-080
OAAI
3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia

3D肿瘤微环境相互作用揭示了慢性淋巴细胞白血病中AP-1复合物的调控以及骨髓基质细胞的接触介导重编程

2025-08-130
OA
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply

局部免疫效应细胞相关毒性综合征在难治性系统性红斑狼疮CAR T细胞治疗患者中的应用——作者回复

2025-08-120
PRE
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma

CD19靶向CAR T细胞疗法在SLE患者和B细胞淋巴瘤患者中的安全性特征比较

Blood
IF23.1
2025-06-140
PRE
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment

大型B细胞淋巴瘤会印刻一种功能失调的免疫表型,该表型在治疗后数年仍然持续存在。

Blood
IF23.1
2025-05-150
OAAI
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT

CD47表达的增强损害了allo-HCT后allo反应性T细胞的清除

Blood
IF23.1
2025-05-090
PRE
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
2025-03-170
OAAI
Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders

成功产生完全人的第二代anti-CD19 CAR T细胞,用于各种自身免疫性疾病患者的临床

2025-02-012
OAAI
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany

WERA癌症中心矩阵: 德国大部分农村地区患者获得精确肿瘤学的战略管理

2024-08-010
OAAI